REGENERON PHARMACEUTICALS, INC. Accrued Liabilities 2009-2025 | REGN
What is accrued liabilities?
Accrued liabilities are expenses that have been incurred but not yet paid, such as wages, interest, and taxes payable.
What is REGENERON PHARMACEUTICALS, INC.'s current accrued liabilities?
REGENERON PHARMACEUTICALS, INC. (REGN) annual accrued liabilities for 2025 was $2.88B, a 13.82% increase from 2024. REGENERON PHARMACEUTICALS, INC. accrued liabilities for the quarter ending December 31, 2025 was $2.88B.
What was REGENERON PHARMACEUTICALS, INC.'s accrued liabilities in 2024?
REGENERON PHARMACEUTICALS, INC. annual accrued liabilities for 2024 was $2.53B, a 7.18% increase from 2023.
What was REGENERON PHARMACEUTICALS, INC.'s accrued liabilities in 2023?
REGENERON PHARMACEUTICALS, INC. annual accrued liabilities for 2023 was $2.36B, a 13.68% increase from 2022.
What is REGENERON PHARMACEUTICALS, INC.'s 5-year accrued liabilities CAGR?
REGENERON PHARMACEUTICALS, INC. accrued liabilities grew at a compound annual growth rate (CAGR) of 11.84% from FY2020 to FY2025, going from $1.64B to $2.88B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $2.88B | +13.8% | 10-K |
| FY2024 | $2.53B | +7.2% | 10-K |
| FY2023 | $2.36B | +13.7% | 10-K |
| FY2022 | $2.07B | -6.0% | 10-K |
| FY2021 | $2.21B | +34.2% | 10-K |
| FY2020 | $1.64B | +35.7% | 10-K |
| FY2019 | $1.21B | +56.9% | 10-K |
| FY2018 | $772.1M | +21.2% | 10-K |
| FY2017 | $637.2M | -27.5% | 10-K |
| FY2016 | $879.1M | +36.5% | 10-K |
| FY2015 | $644.1M | +33.2% | 10-K |
| FY2014 | $483.5M | +92.7% | 10-K |
| FY2013 | $250.9M | +125.3% | 10-K |
| FY2012 | $111.3M | +16.4% | 10-K |
| FY2011 | $95.6M | +78.2% | 10-K |
| FY2010 | $53.7M | +9.4% | 10-K |
| FY2009 | $49.0M | - | 10-K |